Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

RJ Slebos

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Genes & Molecular Sequences

Disorders

Physiology

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ceha H M; Nasser I; Medema R H; Slebos R J
Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
Slebos R J; Baas I O; Clement M J; Offerhaus G J; Askin F B; Hruban R H; Westra W H
p53 alterations in atypical alveolar hyperplasia of the human lung.
Ceha H M; Clement M J; Polak M M; Offerhaus G J; Slebos R J
Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of RJ Slebos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

1998: Ceha H M; Nasser I; Medema R H; Slebos R J
Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
Biochemical and biophysical research communications 1998;249(2):550-5.
1998: Slebos R J; Baas I O; Clement M J; Offerhaus G J; Askin F B; Hruban R H; Westra W H
p53 alterations in atypical alveolar hyperplasia of the human lung.
Human pathology 1998;29(8):801-8.
1998: Ceha H M; Clement M J; Polak M M; Offerhaus G J; Slebos R J
Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas.
Pancreas 1998;17(1):85-8.
1998: Wilentz R E; Chung C H; Sturm P D; Musler A; Sohn T A; Offerhaus G J; Yeo C J; Hruban R H; Slebos R J
K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Cancer 1998;82(1):96-103.
1997: Hruban R H; Sturm P D; Slebos R J; Wilentz R E; Musler A R; Yeo C J; Sohn T A; van Velthuysen M L; Offerhaus G J
Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
The American journal of pathology 1997;151(4):943-9.
1997: Entius M M; Westerman A M; Giardiello F M; van Velthuysen M L; Polak M M; Slebos R J; Wilson J H; Hamilton S R; Offerhaus G J
Peutz-Jeghers polyps, dysplasia, and K-ras codon 12 mutations.
Gut 1997;41(3):320-2.
1997: Dijkhuizen S M; Entius M M; Clement M J; Polak M M; Van den Berg F M; Craanen M E; Slebos R J; Offerhaus G J
Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential.
Gastroenterology 1997;112(2):561-6.
1996: Slebos R J; Baas I O; Clement M; Polak M; Mulder J W; van den Berg F M; Hamilton S R; Offerhaus G J
Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
British journal of cancer 1996;74(2):165-71.
1996: Chung C H; Wilentz R E; Polak M M; Ramsoekh T B; Noorduyn L A; Gouma D J; Huibregtse K; Offerhaus G J; Slebos R J
Clinical significance of K-ras oncogene activation in ampullary neoplasms.
Journal of clinical pathology 1996;49(6):460-4.
1996: Westra W H; Baas I O; Hruban R H; Askin F B; Wilson K; Offerhaus G J; Slebos R J
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
Cancer research 1996;56(9):2224-8.
1996: Baas I O; van den Berg F M; Mulder J W; Clement M J; Slebos R J; Hamilton S R; Offerhaus G J
Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms.
The Journal of pathology 1996;178(3):264-7.
1994: Kern J A; Slebos R J; Top B; Rodenhuis S; Lager D; Robinson R A; Weiner D; Schwartz D A
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
The Journal of clinical investigation 1994;93(2):516-20.
1993: Westra W H; Slebos R J; Offerhaus G J; Goodman S N; Evers S G; Kensler T W; Askin F B; Rodenhuis S; Hruban R H
K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.
Cancer 1993;72(2):432-8.
1993: Westra W H; Offerhaus G J; Goodman S N; Slebos R J; Polak M; Baas I O; Rodenhuis S; Hruban R H
Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.
The American journal of surgical pathology 1993;17(3):213-20.
1992: Slebos R J; Boerrigter L; Evers S G; Wisman P; Mooi W J; Rodenhuis S
A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1992;1(2):136-41.
1992: Rodenhuis S; Slebos R J
Clinical significance of ras oncogene activation in human lung cancer.
Cancer research 1992;52(9 Suppl):2665s-2669s.
1992: Slebos R J; Rodenhuis S
The ras gene family in human non-small-cell lung cancer.
Journal of the National Cancer Institute. Monographs 1992;(13):23-9.
1991: Oudejans J J; Slebos R J; Zoetmulder F A; Mooi W J; Rodenhuis S
Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver.
International journal of cancer. Journal international du cancer 1991;49(6):875-9.
1991: Slebos R J; Hruban R H; Dalesio O; Mooi W J; Offerhaus G J; Rodenhuis S
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.
Journal of the National Cancer Institute 1991;83(14):1024-7.
1991: Slebos R J; Habets G G; Evers S G; Mooi W J; Rodenhuis S
Allele-specific detection of K-ras oncogene expression in human non-small-cell lung carcinomas.
International journal of cancer. Journal international du cancer 1991;48(1):51-6.
1991: Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
Cancer research 1991;51(3):958-63.
1990: Rodenhuis S; Slebos R J
The ras oncogenes in human lung cancer.
The American review of respiratory disease 1990;142(6 Pt 2):S27-30.
1990: Slebos R J; Kibbelaar R E; Dalesio O; Kooistra A; Stam J; Meijer C J; Wagenaar S S; Vanderschueren R G; van Zandwijk N; Mooi W J
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
The New England journal of medicine 1990;323(9):561-5.
1989: Breuer M; Slebos R; Verbeek S; van Lohuizen M; Wientjens E; Berns A
Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.
Nature 1989;340(6228):61-3.
1989: Slebos R J; Rodenhuis S
The molecular genetics of human lung cancer.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1989;2(5):461-9.
1989: Slebos R J; Evers S G; Wagenaar S S; Rodenhuis S
Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.
British journal of cancer 1989;59(1):76-80.
1988: Rodenhuis S; Slebos R J; Boot A J; Evers S G; Mooi W J; Wagenaar S S; van Bodegom P C; Bos J L
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
Cancer research 1988;48(20):5738-41.
1988: Slebos R J; de Graeff A; Van Zandwijk N; Mooi W J; Bos J L; Rodenhuis S
Recurrent breast cancer and an adenocarcinoma of the lung occurring in one patient: c-myc oncogene amplification and K-ras codon 12 point mutation as tumour markers.
European journal of cancer & clinical oncology 1988;24(9):1529-30.
1988: de Graeff A; Slebos R J; Rodenhuis S
Resistance to cisplatin and analogues: mechanisms and potential clinical implications.
Cancer chemotherapy and pharmacology 1988;22(4):325-32.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

RJ Slebos

Research Profile (preview)

Genes & Molecular Sequences

Disorders

Physiology

Chemicals & Drugs

Procedures

Activities & Behaviors

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of RJ Slebos (preview)

All Publications